## [Anaesthesia Primary Exam](https://ketaminenightmares.com/pex)

### Pharmacology SAQ

#### Muscle Relaxants

- [2000B16 Atracurium vs cisatracurium](2000B16_atracurium_vs_cisatracurium.htm)
- [2004A02 Non-depolarising relaxants - rate of onset](2004A02_non_depolarising_relaxants_rate_of_onset.htm)
- [2006B04 Suxamethonium vs rocuronium - rapid sequence induction](2006B04_suxamethonium_vs_rocuronium_in_rapid_sequence_induction.htm)
- [2007B06 Suxamethonium - mechanisms of phase 1 and phase 2 block](2007B06_suxamethonium_mechanisms_of_phase_1_and_phase_2_blockade.htm)
- [2009B05 Non-depolarising relaxants - inter-individual variation](2009B05_non_depolarising_relaxants_inter_individual_variation.htm)
- [2010B05 Reversal - anti-cholinesterases](2010B05_reversal_anticholinesterases.htm)
- [2013C04 Relaxants - cardiovascular effects](2013C04_relaxants_cardiovascular_effects.htm)
- [2014A02 Non-depolarising relaxants - log dose response curve](2014A02_non_depolarising_relaxants_log_dose_response_curve.htm)
- [2016A04 Non-depolarising relaxants - adverse effects](2016A04_non_depolarising_relaxants_adverse_effects.htm)
- [2016B10 Reversal - neostigmine](2016B10_reversal_neostigmine.htm)
- [2018A12 Reversal - neostigmine vs sugammadex](2018A12_reversal_neostigmine_vs_sugammadex.htm)
- [2018B04 Suxamethonium vs rocuronium](2018B04_suxamethonium_vs_rocuronium.htm)
- [2019A12 Non-depolarising relaxants - rate of offset](2019A12_non_depolarising_relaxants_rate_of_offset.htm)
- [2019B01 Suxamethonium - adverse effects](2019B01_suxamethonium_adverse_effects.htm)
- [2020A14 Neostigmine - adverse effects](2020A14_neostigmine_adverse_effects.htm)
